Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – Here’s What Happened

Know Labs, Inc. (NYSEAMERICAN:KNW) shares rose 3.8% during trading on Friday . The company traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares were traded during trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Price Performance

The company has a market capitalization of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83. The business has a fifty day moving average price of $2.14 and a 200 day moving average price of $2.14.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Know Labs stock. Corient Private Wealth LLC purchased a new stake in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned 0.67% of Know Labs as of its most recent filing with the Securities and Exchange Commission (SEC). 23.96% of the stock is currently owned by institutional investors and hedge funds.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non?invasive sensing solutions based on its proprietary Bio?RFID platform. The technology employs low?power radio?frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal?processing algorithms to reflected electromagnetic waves, the company aims to deliver real?time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.